Rare diseases
Investigational molecules
Locations
Back to France3 345 clinical trials in St Germain En Laye, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Efficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
FrancePhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
FranceSafety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE
FranceStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
FranceSafety, Tolerability and Efficacy of Intracochlear SENS-601 in Children with GJB2‑Related Hearing Loss
FranceLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
FrancePhase 2 Study of Safety and Efficacy of PF-08634404 Alone or with Drug Combination in Adults with Early-Stage or Locally Advanced Non-Small Cell Lung Cancer
FranceStudy of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers
FranceFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
FranceAzenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer
FrancePhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
FrancePhase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations
FranceThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative combination therapies for follicular lymphoma, comparing mosunetuzumab plus lenalidomide against standard treatments to improve progression-free survival in previously untreated patients.
Research focuses on enhancing treatment outcomes for high-risk lymphoma patients.
Evaluating treatment strategies for elderly women with HER2-negative breast cancer, examining the effectiveness of combined chemotherapy and hormone therapy based on genomic profiling.
Studies aim to optimize treatment outcomes for senior patients while considering their specific needs.
Investigating treatment optimization for Secondary Progressive Multiple Sclerosis patients, focusing on the safety and efficacy of disease-modifying therapy withdrawal in stable patients over 50.
Research aims to enhance quality of life while maintaining disease stability.
Examining preventive strategies for pregnancy-associated hypertension and pre-eclampsia through controlled trials of acetylsalicylic acid treatment in pregnant women with chronic hypertension.
Focus on reducing maternal and fetal morbidity through preventive care.
Investigating the effects of preoperative cholecalciferol supplementation on post-thyroidectomy outcomes, specifically focusing on preventing hypocalcemia complications.
Research aims to improve patient recovery and reduce hospital stays after thyroid surgery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
